News

Get in touch today

If you would like to know more about our company and its products, or discuss how you could support our work to produce market-leading orthobiologics products, we’d love to hear from you.

Get in touch

First Participant Treated in Groundbreaking LDGraft RESTORE Study for Spinal Fusion

Locate Bio Raises £9.2m for LDGraft ALIF Study

Locate Bio’s LDGraft Granted FDA Breakthrough Device Designation

Programmed Drug Release of rhBMP-2 for Bone Healing

Locate Bio Closes £10 million Funding Round

Locate Bio appoints Keith Valentine as the Non-Executive Chair of the Board of Directors

Locate Bio raises £2.25m for new spinal treatments

Locate Bio announces the appointment of John von Benecke as CEO

Locate Bio receives £2.0 million investment from Mercia and the MEIF to expand its cell and gene therapy pipeline

Locate Therapeutics announces name change to Locate Bio and new investment from Mercia Technologies PLC

Get in touch today

About LocateBio

Links

Legals